Stocktoria

Mirum Pharmaceuticals, Inc. MIRM

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2019-07-18 · LEI

Mirum Pharmaceuticals, Inc. statistics & valuation

Market cap$7.5B
P / S14.5×
P / B24.0×
P / FCF137.5×
Net margin-4.5%
Return on equity-7.4%
FCF margin10.5%
Return on capital-3.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-438.90% -176.00% -87.70% -26.10% -4.50% 2019202020212022202320242025
Gross margin (%)
2019202020212022202320242025
Operating margin (%)
-906.10% -170.30% -58.60% -26.00% -4.20% 2019202020212022202320242025
Return on equity (%)
-40.30% -60.00% -69.90% -95.50% -65.70% -39.00% -7.40% 2019202020212022202320242025
Shares outstanding
22.6M 29.8M 30.6M 37.0M 46.7M 48.3M 51.9M 2019202020212022202320242025
Net debt ($)
2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-35.80% -42.90% -28.50% -38.40% -25.30% -13.10% -2.80% 2019202020212022202320242025
Free cash flow margin (%)
-693.80% -156.30% -38.10% 2.80% 10.50% 2019202020212022202320242025
Debt / equity (×)
2019202020212022202320242025
EPS ($)
-$2.77 -$4.02 -$4.00 -$1.85 -$0.47 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin-4.2%-26.0%-58.6%-170.3%-906.1%——
Net margin-4.5%-26.1%-87.7%-176.0%-438.9%——
FCF margin10.5%2.8%-38.1%-156.3%-693.8%——
Return on assets-2.8%-13.1%-25.3%-38.4%-28.5%-42.9%-35.8%
Return on equity-7.4%-39.0%-65.7%-95.5%-69.9%-60.0%-40.3%
Current ratio2.673.104.452.943.9112.809.13

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.